Calcium with Vitamin D Chewable Tablet
Natural health product licensed in Canada
- Other names
- Polar Bear Calcium with Vitamin D Chewable Tablet
- Licence holder
- Polar Bear Canada Corporation
- NPN or DIN-HM
- 80083305
- Status
- Active licence
- Licence date
- 20 February 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada (8 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Hydroxyde de magnésium | 50 mg | 400,000 µg |
Non-medicinal ingredients
Sorbitol, Dioxyde de silicium, Cellulose microcristalline, Dextrates, Sucre, Saveur d'orange, Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et Adolescents | minimum: 9 years ; maximum: 12 years | minimum: 3 Comprimé ; maximum: 4 Comprimé | 1 Tous les jours |
| Enfants | minimum: 4 years ; maximum: 8 years | 2 Comprimé | 1 Tous les jours |
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 4 Comprimé | 2 Tous les jours |
| Enfants | minimum: 1 year ; maximum: 3 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps in the development and maintenance of bones and teeth especially in childhood, adolescence and young adulthood. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps to prevent vitamin D, calcium and magnesium deficiency. Helps the body to metabolize carbohydrates, fats and proteins. Helps in tissue formation. Helps to maintain proper muscle function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Take a few hours before or after taking other medications. Do not use if safety seal is broken. Keep out of reach of children.
Source
Official Health Canada record, licence 80083305
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.